Live Quote · NYSERCUSHealthcare· Biotechnology

Arcus Biosciences, Inc.

$15.62▼ 1.01%($-0.16)
MKT CAP $2.25BNEXT EARNINGS Feb 24, 2027
50%
Bullish
TickerSpark Score
44/100
▌ Weak
50
Valuation
40
Profitability
20
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RCUS research report →

Analyst Price Target
$40.67+160.4% vs. today

Range $23 – $50

Analyst RatingBuy
15 Buy3 Hold0 Sell

Price Chart

-25.01% · this period
$31.57$23.66$15.76Nov 20May 26Nov 20
52-Week Range0% of range
Low
$15.56
Current
$15.62
High
$31.74